BeStock  

ICU Medical ICUI

US equityMarket cap rank #2163Medical Instruments & Supplies
$172.52 −$3.24 (-1.84%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $172.52 0.00%
Open$177.17
Prev close$175.76
Day range$171.40 – $178.52
Volume223.4K
Market cap$4.31B
P/E (TTM)72.2
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$560.44M+4.4% YoY
Operating profit$58.59M+118.2% YoY
Net profit$26.85M+890.5% YoY
Diluted EPS$1.07+864.3% YoY
Free cash flow$81.71M+227.4% YoY
Operating cash flow$99.59M

Revenue, last 8 quarters

$629.8MDec '24$604.7MMar '25$548.9MJun '25$537.0MSep '25$540.7MDec '25$530.2MMar '26$551.7MJun '26$560.4MSep '26

Net profit, last 8 quarters

$-23.8MDec '24$-15.5MMar '25$35.3MJun '25$-3.4MSep '25$-15.7MDec '25$30.1MMar '26$19.1MJun '26$26.8MSep '26

Diluted EPS by quarter

-0.97Dec '24-0.63Mar '251.43Jun '25-0.14Sep '25-0.64Dec '251.20Mar '260.76Jun '261.07Sep '26

Free cash flow by quarter

$13.6MDec '24$34.5MMar '25$-10.8MJun '25$25.0MSep '25$34.2MDec '25$25.7MMar '26$60.0MJun '26$81.7MSep '26

Annual revenue

$1.3BFY20$1.3BFY21$2.3BFY22$2.3BFY23$2.4BFY24$2.2BFY25

Profitability & balance sheet

Gross margin40.3%
Operating margin8.0%
Net margin2.8%
Return on equity2.8%
Return on assets1.5%
Return on invested capital2.9%
Current ratio2.37
Liabilities / assets44.4%
Cash & investments$301.78M
Total debt$1.19B
Net cash (debt)-$889.94M
Free cash flow / sales9.2%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Consumables$298.40M 53.2%
  • Infusion Systems$192.53M 34.4%
  • Vital Care$69.51M 12.4%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $560.44M $551.68M $530.23M $2.23B $540.70M
Total Operating Revenue $560.44M $551.68M $530.23M $2.23B $540.70M
Cost of Revenue $325.69M $316.63M $324.00M $1.41B $337.72M
Gross Profit $234.75M $235.05M $206.23M $822.04M $202.99M
Operating Expense $176.16M $174.62M $175.85M $712.71M $176.90M
Selling and Admin Expenses $154.41M $151.92M $154.57M $625.21M $155.81M
Research & Development $21.75M $22.70M $21.28M $87.50M $21.09M
Operating Profit $58.59M $60.43M $30.38M $109.33M $26.09M
Net Non-Operating Interest Income (Expense) -$15.24M -$15.75M -$16.49M -$83.03M -$20.64M
Non-Operating Interest Income $2.86M $2.81M $2.04M $10.31M $2.14M
Non-Operating Interest Expense $18.10M $18.56M $18.53M $93.34M $22.78M
Other Income (Expense) -$7.17M -$21.54M -$17.86M -$21.95M -$21.35M
Gain on Sale of Security -$423,000.00 -$853,000.00 -$908,000.00 $3.79M $1.82M
Special Income (Charges) -$7.10M -$21.87M -$16.94M -$26.08M -$23.13M
-Less:Restructuring and Mergern & Acquisition $6.27M $21.30M $16.80M $66.51M $20.45M
-Less:Write Off $2.83M – – – –
-Gain on Sale Of Business $2.24M $0.00 – $44.79M $0.00
-Gain on Sale of Property/Plant/Equipment -$232,000.00 -$567,000.00 -$135,000.00 -$4.37M -$2.68M
Other Non-Operating Income (Expenses) $345,000.00 $1.18M -$17,000.00 $348,000.00 -$32,000.00
Pretax Profit $36.18M $23.14M -$3.98M $4.36M -$15.90M
Tax $7.19M $7.07M -$34.71M $2.44M -$2.65M
$2.14M -$3.01M $607,000.00 $1.19M $2.49M
Net Profit $26.85M $19.09M $30.13M $732,000.00 -$15.73M
Profit from Continuing Operations $26.85M $19.09M $30.13M $732,000.00 -$15.73M
Net Income to Parent Company $26.85M $19.09M $30.13M $732,000.00 -$15.73M
Net Income to Common Stockholders $26.85M $19.09M $30.13M $732,000.00 -$15.73M
Basic EPS $1.07 $0.76 $1.22 $0.03 -$0.64
Diluted EPS $1.07 $0.76 $1.20 $0.03 -$0.64

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $3.94B $3.97B $4.01B $4.05B $4.05B
Total Current Assets $1.22B $1.21B $1.21B $1.19B $1.19B
Cash and Cash Equivalents & Short-Term Investments $301.78M $298.30M $288.33M $307.96M $307.96M
-Cash and Cash Equivalents $301.78M $298.30M $288.33M $307.96M $307.96M
Receivables $236.97M $218.64M $226.82M $203.91M $203.91M
-Accounts Receivable $206.26M $183.53M $201.08M $180.52M $180.52M
-Taxes Receivable $10.75M $10.36M – – –
-Other Receivables $19.97M $24.75M $25.74M $23.39M $23.39M
Prepaid Assets $22.98M $25.45M $24.23M $25.47M $25.47M
Inventory $607.27M $607.42M $605.59M $615.86M $615.86M
Current Deferred Assets $26.34M $21.46M $24.26M $13.11M $13.11M
Other Current Assets $24.53M $34.35M $38.61M $20.50M $20.50M
Total Non-Current Assets $2.72B $2.76B $2.80B $2.86B $2.86B
Net PPE $481.16M $485.41M $495.93M $511.89M $511.89M
-Gross PPE $1.17B $1.16B $1.16B $1.16B $1.16B
-Accumulated Depreciation -$690.29M -$675.61M -$660.72M -$645.91M -$645.91M
Investments and Advances $128.93M $133.91M $130.92M $131.59M $131.59M
-Long Term Equity Investment $128.93M $133.91M $130.92M $131.59M $131.59M
Goodwill and Other Intangible Assets $2.02B $2.05B $2.08B $2.13B $2.13B
-Goodwill $1.48B $1.48B $1.49B $1.50B $1.50B
-Other Intangible Assets $536.47M $567.67M $598.97M $633.56M $633.56M
Non-Current Deferred Assets $25.44M $25.57M $25.65M $25.89M $25.89M
Other Non-Current Assets $69.16M $63.44M $63.50M $53.46M $53.46M
Total Liabilities $1.75B $1.82B $1.90B $1.93B $1.93B
Total Current Liabilities $514.63M $498.36M $517.90M $498.86M $498.86M
Payables $153.08M $157.13M $184.58M $164.77M $164.77M
-Accounts Payable $142.99M $149.17M $173.98M $154.37M $154.37M
-Total Tax Payable $10.09M $7.96M $10.60M $10.40M $10.40M
Current Accrued Expenses $201.69M $200.65M $204.43M $196.10M $196.10M
Short-Term Debt and Capital Lease Obligation $18.75M $18.75M $18.75M $18.75M $18.75M
-Current Debt $18.75M $18.75M $18.75M $18.75M $18.75M
Current Provisions $26.30M $25.67M $25.08M $24.60M $24.60M
Current Deferred Liabilities $63.37M $54.37M $60.66M $33.84M $33.84M
Total Non-Current Liabilities $1.24B $1.32B $1.38B $1.43B $1.43B
Long Term Accounts Payable and Other Payables $26.92M $25.40M $25.26M $34.61M $34.61M
Long Term Debt and Capital Lease Obligation $1.17B $1.25B $1.31B $1.31B $1.31B
-Long Term Debt $1.13B $1.21B $1.26B $1.27B $1.27B
-Long Term Capital Lease Obligation $39.87M $40.37M $45.23M $47.68M $47.68M
Non-Current Deferred Liabilities $8.76M $12.23M $14.51M $37.76M $37.76M
Other Non-Current Liabilities $29.10M $30.62M $37.11M $41.86M $41.86M
Total Equity $2.19B $2.15B $2.11B $2.12B $2.12B
Stockholders' Equity $2.19B $2.15B $2.11B $2.12B $2.12B
Capital Stock $2.52M $2.52M $2.52M $2.47M $2.47M
-Common Stock $2.52M $2.52M $2.52M $2.47M $2.47M
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.49B $1.48B $1.47B $1.47B $1.47B
Retained Earnings $766.96M $740.11M $721.02M $690.89M $690.89M
Less: Treasury Stock -$23.04M -$23.42M -$25.18M -$22,000.00 -$22,000.00
Gains/Losses Not Affecting Retained Earnings -$42.17M -$43.34M -$51.90M -$34.63M -$34.63M
Financial Assets – – – $3.82M $3.82M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $99.59M $80.15M $38.91M $179.85M $60.60M
Net cash flow from continuing operations $99.59M $80.18M $38.88M $179.85M $60.60M
Net Income from Continuing Operations $26.85M $19.09M $30.13M $732,000.00 -$15.73M
Gain/Loss from Continuing Operations -$9,000.00 -$1.17M $743,000.00 -$35.24M $7.64M
Depreciation & Depletion & Amortization $49.59M $49.64M $50.00M $200.74M $50.83M
Other Non-Cash Items $11.03M $15.22M $7.96M $47.90M $10.83M
Change in Working Capital $260,000.00 -$14.50M -$63.94M -$90.04M -$6.84M
-Change in Receivables -$21.99M $16.58M -$24.15M $8.88M $4.93M
-Change in Inventory -$2.31M -$1.46M $6.09M -$26.25M $9.96M
-Change in Prepaid Assets $7.75M -$2.11M -$14.35M -$10.96M -$6.24M
-Change in Payables and Accrued Expense $12.89M -$21.11M $10.30M -$29.97M -$24.41M
-Change in Other Current Assets $1.20M -$573,000.00 -$2.36M -$6.98M $167,000.00
-Change In Other Working Capital $2.71M -$5.82M -$39.48M -$24.76M $8.74M
Net cash flow from investing -$13.93M -$20.14M -$11.21M $122.23M -$18.39M
Net Cash Flow from Continuing Investing Activities -$13.93M -$20.14M -$11.21M $122.23M -$18.39M
Net PPE Purchase and Sale -$16.19M -$18.51M -$11.30M -$88.04M -$24.65M
Net Intangibles Purchase and Sale -$1.69M -$1.65M -$1.91M -$8.97M -$1.76M
Net Business Purchase and Sale $3.93M $0.00 $2.00M $211.19M $0.00
Net Other Investing Changes $17,000.00 $21,000.00 $1,000.00 $8.06M $8.02M
Financing Cash Flow -$80.97M -$50.24M -$44.12M -$311.53M -$34.49M
Net Cash Flow from Continuing Financing Activities -$80.97M -$50.24M -$44.12M -$311.53M -$34.49M
Net Issuance Payments Of Debt -$80.67M -$50.64M -$5.35M -$304.49M -$30.19M
Proceeds from Stock Option Exercised $0.00 $490,000.00 $0.00 $6.11M $134,000.00
Net Other Financing Charges -$304,000.00 -$86,000.00 -$38.78M -$13.15M -$4.43M
Ending Cash Balance $301.78M $298.30M $288.33M $307.96M $307.96M
Net Change in Cash $4.69M $9.78M -$16.42M -$9.45M $7.72M
Beginning Cash Balance $298.30M $288.33M $307.96M $308.57M $299.73M
Effect of Exchange Rate Changes -$1.20M $191,000.00 -$3.21M $8.85M $508,000.00
Free Cash Flow $81.71M $59.99M $25.70M $82.83M $34.19M
Net Investment Purchase and Sale – – – $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on ICUI.

Sign in to join the discussion.

Scroll to Top